$ZGNX - FDA OKs Zogenix's Fintepla for Dravet syndrome https://t.co/vdfppIz1AN
This tweet is a neutral one. The author is simply informing the reader of a recent event related to a medical treatment for Dravet Syndrome, without expressing any particular opinion or emotion. Therefore, the output is 1 for neutral emotion.